VOLTAFLEX
LIVE

Serial Number

79199996

Owner

NOVARTIS AG

Filing Date

Dec 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VOLTAFLEX Trademark

Serial Number: 79199996 • Registration: 5215883

VOLTAFLEX is a trademark filed by NOVARTIS AG on December 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 1, 2016

Registration Date

June 6, 2017

Published for Opposition

March 21, 2017

Cancellation Date

December 22, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Sep 29, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 4, 2024 INTS
INVALIDATION PROCESSED
Sep 4, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 23, 2024 INTR
CANCELLED SECTION 71
Dec 22, 2023 C71T
NOTIFICATION PROCESSED BY IB
Jul 28, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 7, 2017 FICS
FINAL DISPOSITION PROCESSED
Jul 7, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 6, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 6, 2017 R.PR
PUBLISHED FOR OPPOSITION
Mar 21, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Mar 17, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 1, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 1, 2017 OP2R
NOTICE OF PUBLICATION
Mar 1, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2017 CNSA
ASSIGNED TO EXAMINER
Feb 8, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 21, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 13, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 5, 2017 SDRC